CA1004142A - Dosage form of n-4(2-(5-chloro-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'- cyclohexyl urea and its salts and process for preparing same - Google Patents

Dosage form of n-4(2-(5-chloro-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'- cyclohexyl urea and its salts and process for preparing same

Info

Publication number
CA1004142A
CA1004142A CA184,767A CA184767A CA1004142A CA 1004142 A CA1004142 A CA 1004142A CA 184767 A CA184767 A CA 184767A CA 1004142 A CA1004142 A CA 1004142A
Authority
CA
Canada
Prior art keywords
methoxybenzamido
phenylsulfonyl
chloro
salts
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA184,767A
Other languages
English (en)
Other versions
CA184767S (en
Inventor
Bernhard Reul
Gerhard Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of CA1004142A publication Critical patent/CA1004142A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA184,767A 1972-10-31 1973-10-30 Dosage form of n-4(2-(5-chloro-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'- cyclohexyl urea and its salts and process for preparing same Expired CA1004142A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2253317 1972-10-31
DE2253318 1972-10-31

Publications (1)

Publication Number Publication Date
CA1004142A true CA1004142A (en) 1977-01-25

Family

ID=25764031

Family Applications (1)

Application Number Title Priority Date Filing Date
CA184,767A Expired CA1004142A (en) 1972-10-31 1973-10-30 Dosage form of n-4(2-(5-chloro-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'- cyclohexyl urea and its salts and process for preparing same

Country Status (8)

Country Link
US (1) US3883648A (pt)
JP (1) JPS5046821A (pt)
AT (1) AT341099B (pt)
CA (1) CA1004142A (pt)
DE (1) DE2355743A1 (pt)
FR (1) FR2204425B1 (pt)
GB (1) GB1445995A (pt)
NL (1) NL7314765A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
DE2966564D1 (en) * 1978-11-20 1984-02-23 American Home Prod Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3325986C2 (de) * 1983-07-19 1985-05-23 Klinge Pharma GmbH, 8000 München Schnell resorbierbare Zubereitung schwer löslicher Wirkstoffe
DE3326167A1 (de) * 1983-07-20 1985-02-21 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
KR870007114A (ko) * 1986-01-21 1987-08-14 우에노 기미오 티올 에스테르 유도체의 안정된 고형제
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
EP1882414A1 (de) * 2006-07-29 2008-01-30 Bayer CropScience AG Schmelzgranulate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
DE1467938C3 (de) * 1964-05-22 1973-12-20 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Wasserdispergierbares Arzneipräparat für Tiere
FR1487897A (fr) * 1965-07-27 1967-07-07 Hoechst Ag Benzène-sulfonyl-urées et leur préparation
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
SE335202B (pt) * 1968-06-19 1971-05-17 Aco Laekemedel Ab
NL7112288A (pt) * 1970-09-16 1972-03-20
DE2055930A1 (de) * 1970-11-13 1972-05-18 Boehringer Mannheim Gmbh, 6800 Mannheim Verbesserte orale Applikationsform von Raubasin

Also Published As

Publication number Publication date
FR2204425B1 (pt) 1977-04-22
NL7314765A (pt) 1974-05-02
AT341099B (de) 1978-01-25
DE2355743A1 (de) 1975-05-22
GB1445995A (en) 1976-08-11
JPS5046821A (pt) 1975-04-25
US3883648A (en) 1975-05-13
FR2204425A1 (pt) 1974-05-24
ATA916573A (de) 1977-05-15

Similar Documents

Publication Publication Date Title
HU172927B (hu) Sposob poluchenija azolil-/1/-metanov, ikh solej i lechebnykh preparatov soderzhahhikh takoe aktivnoe vehhestvo
CA1004142A (en) Dosage form of n-4(2-(5-chloro-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'- cyclohexyl urea and its salts and process for preparing same
BE806833A (fr) Nouveau procede de preparation d'insuline, de ses analogues et derives
BE806522A (fr) Procede de preparation d'insuline, de ses analogues et derives
AU467578B2 (en) New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame
GR60385B (en) New propargyl-2-phenylamino-imidazolines-(2),salts thereof by addition of their acids,pharmaceutical mediums containing the above and process for their preparation
BE817649A (fr) Procede de preparation d'insuline-metal alcalin et d'insuline-ammonium
FR2284595A1 (fr) Procede de preparation de nicotinamide et d'isonicotinamide
PH15346A (en) 2-(n-thienylmethyl-phenylamino)-imidazolines-(2)and salts thereof
SU576040A3 (ru) Способ получени -(3,3-дифенилпропил)-пропилендиаминов или их солей
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
YU166370A (en) Process for preparing n, n-bis-(2-(3, 4-dihydroxyphenyl)-2-hydroxyethyl)-hexamethylene diamine, optically active derivatives and salts thereof
YU299679A (en) Process for obtaining novel derivatives of aminoimidazoisoquinoline and salts thereof
EG11264A (en) Process for the preparation of basic esters and salts thereof
BE772403A (fr) Procede de preparation de l'isoprene a partir d'isobutene et deformaldehyde
PH11943A (en) 2,2"-anhydro-1-b-d-arabinofuranosyl-5-fluorocytosine salts and process of preparation
IL48465A0 (en) New 6',2-(2'-arylchromonyl)propionic acids and their salts,their preparation and pharmaceutical compositions containing them
BE795994A (fr) Procede de preparation d'inhibiteurs de saccharase
BE811695A (fr) Sels d'amidinohydrazone 1-substituee et procede de leur preparation
CS187383B2 (en) Agent for regulation of the plant's growth and method of preparation of its active substance
EG11385A (en) Process for preparing of 1-phenyl-2-(1'1'-diphenylpropyl(3')-amino)-propanes
CA969939A (en) Process for preparing benzomorphan derivatives and salts thereof
AU465546B2 (en) Process for preparing salts of -d-glucose-1-phosphoric acid and products obtained
CA1008452A (en) 1-acyl-homopyrimidazole-derivatives and salts thereof and process for their preparation
AU482008B2 (en) New 1-acyl-homopyrimidazole-derivatives and salts thereof and process for their preparation